These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 32898638)
1. Microbiological monitoring during aseptic handling: Methods, limits and interpretation of results. Boom FA; Brun PPHL; Bühringer S; Touw DJ Eur J Pharm Sci; 2020 Dec; 155():105540. PubMed ID: 32898638 [TBL] [Abstract][Full Text] [Related]
2. Microbiological controls of aseptic handling in Dutch hospital pharmacies: Results, limits, and methods for assessing. Boom FA; Le Brun PPH; Bühringer S; Sirks M; Touw DJ Eur J Pharm Sci; 2022 Aug; 175():106228. PubMed ID: 35640785 [TBL] [Abstract][Full Text] [Related]
3. Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes. Krämer I; Federici M; Kaiser V; Thiesen J J Oncol Pharm Pract; 2016 Apr; 22(2):195-204. PubMed ID: 25549919 [TBL] [Abstract][Full Text] [Related]
4. Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part B: risk control. Boom FA; Ris JM; Veenbaas T; Le Brun PPH; Touw D Eur J Hosp Pharm; 2021 Nov; 28(6):325-330. PubMed ID: 32385068 [TBL] [Abstract][Full Text] [Related]
5. Continuous microbiological air monitoring for aseptic filling lines. Scherwing C; Golin F; Guenec O; Pflanz K; Dalmaso G; Bini M; Andone F PDA J Pharm Sci Technol; 2007; 61(2):102-9. PubMed ID: 17479718 [TBL] [Abstract][Full Text] [Related]
6. Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part C: applying risk assessment and risk control in practice. Boom FA; Le Brun PPH; Ris JM; Veenbaas T; Touw D Eur J Hosp Pharm; 2023 May; 30(3):160-166. PubMed ID: 34233906 [TBL] [Abstract][Full Text] [Related]
7. Environmental Monitoring for Closed Robotic Workcells Used in Aseptic Processing: Data to Support Advanced Environmental Monitoring Strategies. McCall J; Barnard N; Gadient K; Kasireddy C; Kurtz A; Li Y; Page T; Putnam T; Brennan Á AAPS PharmSciTech; 2022 Aug; 23(6):215. PubMed ID: 35922577 [TBL] [Abstract][Full Text] [Related]
8. Improving the aseptic transfer procedures in hospital pharmacies part C: evaluation and redesign of the transfer process. Boom FA; Le Brun PPH; Boehringer S; Kosterink JGW; Touw DJ Eur J Hosp Pharm; 2022 Jan; 29(1):12-17. PubMed ID: 34930789 [TBL] [Abstract][Full Text] [Related]
9. Charting and Evaluation of Environmental Microbial Monitoring Data. Bar R PDA J Pharm Sci Technol; 2015; 69(6):743-61. PubMed ID: 26659105 [TBL] [Abstract][Full Text] [Related]
10. Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo. Schierl R; Masini C; Groeneveld S; Fischer E; Böhlandt A; Rosini V; Paolucci D J Oncol Pharm Pract; 2016 Feb; 22(1):37-45. PubMed ID: 25227229 [TBL] [Abstract][Full Text] [Related]
11. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs. Geersing TH; Franssen EJF; Pilesi F; Crul M Eur J Pharm Sci; 2019 Mar; 130():181-185. PubMed ID: 30710619 [TBL] [Abstract][Full Text] [Related]
12. Multicenter Study on Incubation Conditions for Environmental Monitoring and Aseptic Process Simulation. Guinet R; Berthoumieu N; Dutot P; Triquet J; Ratajczak M; Thibaudon M; Bechaud P; Arliaud C; Miclet E; Giordano F; Larcon M; Arthaud C PDA J Pharm Sci Technol; 2017 1/2; 71(1):43-49. PubMed ID: 27593691 [TBL] [Abstract][Full Text] [Related]
13. Nine years of microbiological air monitoring in the operating theatres of a university hospital in Southern Italy. Squeri R; Genovese C; Trimarchi G; Antonuccio GM; Alessi V; Squeri A; La Fauci V Ann Ig; 2019; 31(2 Supple 1):1-12. PubMed ID: 30994159 [TBL] [Abstract][Full Text] [Related]
14. The Development and Implementation of Airflow Visualization Studies ("Smoke" Studies) as a Training Tool in Aseptic Hospital Compounding Facilities. Borgonje PE; Wibier L; Noordman P; Woerdenbag HJ; Gareb B Pharmacy (Basel); 2022 Aug; 10(5):. PubMed ID: 36136834 [TBL] [Abstract][Full Text] [Related]
15. Exposure to antineoplastic drugs in two UK hospital pharmacy units. Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878 [TBL] [Abstract][Full Text] [Related]
16. Industrial manufacture of parenteral products in The Netherlands. A survey of eight years of media fills and sterility testing. Van Doorne H; Van Kampen BJ; Van der Lee RW; Rummenie L; Van der Veen AJ; De Vries WJ PDA J Pharm Sci Technol; 1998; 52(4):159-64. PubMed ID: 9752710 [TBL] [Abstract][Full Text] [Related]
17. Control of the aseptic processing environment. Frieben WR Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522 [TBL] [Abstract][Full Text] [Related]
18. Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing. Weber J; Hauschild J; Ijzerman-Boon P; Forng RY; Horsch J; Yan L; Prasad A; Henry RB; Claassen M; Villari P; Shereefa S; Wyatt J; Bolden JS; Pycke JT; Dassu D PDA J Pharm Sci Technol; 2019; 73(2):121-134. PubMed ID: 30361285 [TBL] [Abstract][Full Text] [Related]
19. Continuous and Effective Microbiological Air Monitoring in Critical Environments: A Comparison of Analytical Methodologies. Dalmaso G; Campanella A; Lazzeri P PDA J Pharm Sci Technol; 2020; 74(4):446-455. PubMed ID: 32060221 [TBL] [Abstract][Full Text] [Related]
20. Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part A: risk assessment. Boom FA; Ris JM; Veenbaas T; Le Brun PPH; Touw D Eur J Hosp Pharm; 2022 May; 29(3):151-156. PubMed ID: 32385070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]